GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

NCT04942756 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Palliative Care
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 1
Diabetes
Cancer
Terminal Cancer
Terminal Illness
End Stage Cancer
Advanced Cancer

Interventions

DEVICE: Continuous Glucose Monitoring
DEVICE: Standard Care

Sponsor

Antea Foundation

Collaborators

[object Object]